A new, detailed genetic roadmap of glaucoma, revealed by Australian ophthalmologist Professor Alex Hewitt, will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse vision loss.
Scientists are examining key elements of the complex transport system that moves important molecules between the retina and the brain via the optic nerve…
The question of whether sleep apnoea is a risk factor for glaucoma was recently debated in a session at the 2021 World Glaucoma Congress...
Despite increasingly advanced treatments and early intervention, parents and carers, some of whom have been diagnosed with genetic glaucoma themselves, face significant long-term challenges...
Dr Georgie Hollitt is part of a team of Australian researchers who have identified 107 genes that increase the risk of glaucoma...
Dr Dinesh Kumar and other inventors of a new rapid screening test for glaucoma that could help advance early detection of the disease are planning clinical trials starting sometime this year...
Recognising the limitations of current glaucoma screening techniques, including timeliness and cost effectiveness, researchers have seized on the opportunity to target these shortcomings...
With funding from Glaucoma Australia and the National Health and Medical Research Council (NHMRC), researchers from Flinders University are conducting a prospective study to validate a Polygenic Risk Score (PRS) for glaucoma.
An innovative test developed by a world-leading research team has the potential to improve the management and early treatment of glaucoma patients and those at risk of glaucoma.